These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19145088)

  • 1. Prognostic factors in chronic myeloid leukemia (CML).
    Hochhaus A
    Onkologie; 2008 Nov; 31(11):576-8. PubMed ID: 19145088
    [No Abstract]   [Full Text] [Related]  

  • 2. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
    Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
    Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tinnitus: first symptom of chronic myeloid leukemia].
    Mayaleh HA; Portmann D
    Rev Laryngol Otol Rhinol (Bord); 2004; 125(3):163-4. PubMed ID: 15602859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of der(9q) deletions detected through dual-fusion fluorescence in situ hybridization in patients with chronic myeloid leukemia.
    Vaz de Campos MG; Montesano FT; Rodrigues MM; Chauffaille Mde L
    Cancer Genet Cytogenet; 2007 Oct; 178(1):49-56. PubMed ID: 17889708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
    Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
    Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant appearance of trisomy 8 and isochromosome 17q in a Philadelphia-positive clone in a patient with chronic myeloid leukemia in chronic phase: an alarm for changing therapeutic strategy.
    Orciuolo E; Buda G; Galimberti S; Sordi E; Cervetti G; Petrini M
    Cancer Genet Cytogenet; 2007 Sep; 177(2):166-7. PubMed ID: 17854678
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
    Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
    Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
    Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
    Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia.
    Buda G; Orciuolo E; Galimberti S; Benedetti E; Caracciolo F; Cervetti G; Carulli G; Papineschi F; Petrini M
    Leuk Res; 2008 Jan; 32(1):192-4. PubMed ID: 17391755
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients.
    Bianchini M; De Brasi C; Gargallo P; Gonzalez M; Bengió R; Larripa I
    Eur J Haematol; 2009 Apr; 82(4):292-300. PubMed ID: 19191867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor prognosis chronic myeloid leukemia with a complex variant Philadelphia translocation, t(9;10;22)(q34;q24;q11).
    Buda G; Orciuolo E; Cecconi N; Galimberti S; Cervetti G; Petrini M
    Leuk Res; 2007 Dec; 31(12):1765-6. PubMed ID: 17320954
    [No Abstract]   [Full Text] [Related]  

  • 14. Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitors.
    Breccia M; Stagno F; Gozzini A; Abruzzese E; Latagliata R; Rossi AR; Sorà F; Porrini R; Vigneri P; Trawinska M; Montefusco E; Sica S; Specchia G; Santini V; Alimena G
    Am J Hematol; 2011 Jun; 86(6):523-5. PubMed ID: 21594891
    [No Abstract]   [Full Text] [Related]  

  • 15. High incidence of derivative chromosome arm 9q deletions in Asian chronic myelogenous leukemia.
    Tien SL; Rudduck-Sivaswaren C; Lim P; Lim E; Lie DK; Tan PH; Lee AS
    Genes Chromosomes Cancer; 2005 Apr; 42(4):433-4. PubMed ID: 15645497
    [No Abstract]   [Full Text] [Related]  

  • 16. The double deceit generated by an insertion mechanism in chronic myeloid leukemia with t(9;9;22).
    Albano F; Zagaria A; Anelli L; Pannunzio A; Manodoro F; Coccaro N; Russo Rossi A; Liso V; Rocchi M; Specchia G
    Ann Hematol; 2008 Nov; 87(11):923-6. PubMed ID: 18553081
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.
    Hwang YY; Tse E; So JC; Wan TS; Kwong YL
    Am J Hematol; 2009 May; 84(5):302-5. PubMed ID: 19338042
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic myelogenous leukemia exhibiting trisomy 14 due to a Robertsonian translocation with philadelphia chromosome.
    Durmaz B; Karaca E; Vural F; Cogulu O; Alpman A; Tombuloglu M; Ozkinay F
    Acta Oncol; 2008; 47(8):1604-6. PubMed ID: 18607844
    [No Abstract]   [Full Text] [Related]  

  • 19. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
    Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
    Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
    Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
    Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.